We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Enteroviruses Detected in Intestinal Specimens from Children with Advanced Ileocecal Crohn’s Disease

By LabMedica International staff writers
Posted on 09 Jul 2013
Enteroviruses have been detected in specimens taken from all the children in a small cohort with advanced ileocecal Crohn’s disease (ICD), while no enteroviruses were detected in specimens from normal children or from children with colon obstructions not related to Crohn's disease (CD).

Advanced ileocecal Crohn’s disease (ICD) is characterized by strictures, inflammation in the enteric nervous system (myenteric plexitis), and a high frequency of NOD2 (nucleotide-binding oligomerization domain-containing protein 2) mutations. More...
Homozygosity for a mutation in NOD2 increases the risk of the disease by a factor of 20 to 40. NOD2 encodes an intracellular protein that contains two caspase-recruitment domains, a nucleotide-binding domain, and 10 leucine-rich sequence repeats in the C-terminal region.

In addition to its relation to CD, recent findings have indicated a role for NOD2 and another CD susceptibility gene, ATG16L1, in the host response against single-stranded RNA (ssRNA) viruses. Since the role of viruses in CD was unknown, a multidisciplinary team of Swedish investigators hypothesized that human enterovirus species B (HEV-B), which are ssRNA viruses with dual tropism both for the intestinal epithelium and the nervous system, could play a role in ICD.

The research team, which included pediatricians, pathologists, virologists, molecular biologists, cell biologists and geneticists, worked with resections and biopsy specimens from a group comprising nine children with advanced, stricturing ICD, six patients with volvulus (abnormal twisting of the intestine causing obstruction), and 15 CD patients. The investigators used immunohistochemistry and in situ hybridization to demonstrate the presence of HEV-B and of the two HEV-B subspecies, Coxsackie B virus (CBV) and Echovirus.

Results showed that all patients with ICD had disease-associated polymorphisms in NOD2 or ATG16L1. Positive staining for HEV-B was detected both in the mucosa and in myenteric nerve ganglia in all ICD patients, but in none of the volvulus patients. Expression of the cellular receptor for CBV, CAR, was detected in nerve cell ganglia.

The common presence of HEV-B in the mucosa and enteric nervous system of the ICD patients in this small cohort was a novel finding that the investigators considered warranting further investigation to analyze whether HEV-B had a role in disease onset or progress. The presence of CAR in myenteric nerve cell ganglia provided a possible route of entry for CBV into the enteric nervous system.

Senior author Dr. Alkwin Wanders, associate professor of medicine at Uppsala University (Sweden) said, "This unique composition [of researchers], with complementary clinical and scientific expertise, has been extremely fruitful for our studies. Enterovirus could be thought to be stored in nerve cells in the intestine and to spread to different parts of the intestine via nerve fibers. This would explain both the fact that the disease is periodic and the fact that it often affects multiple segments of the intestines."

The study was published in the June 27, 2013, online edition of the journal Clinical and Translational Gastroenterology.

Related Links:
Uppsala University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.